Saturday 04 Apr, 2020 02:34 PM
Site map | Locate Us | Login
   Banks slump as Moody's changes outlook on Indian banks to negative    Shriram Transport Finance Company Ltd leads losers in 'A' group    Pharma stocks buck weak market trend    Ganges Securities Ltd leads losers in 'B' group    Volumes spurt at Gujarat Alkalies & Chemicals Ltd counter    Tata Motors skids after S&P downgrades ratings, outlook stable    Consumer Durables stocks edge lower    Financials shares ease    Banking shares fall    Jammu and Kashmir Bank Ltd eases for fifth straight session    Bharat Forge Ltd slips for fifth straight session    Eicher Motors Ltd slips 1%    RBL Bank Ltd extends losses    NTPC commissions unit-2 of Khargone Super Thermal Power Station    Indian Bank up for third straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Strides Pharma says flagship Bangalore facility gets EIR from USFDA
26-Mar-20   13:08 Hrs IST

Strides Pharma Science's flagship facility, KRS Gardens in Bangalore, Karnataka which was inspected by the United States Food & Drug Administration (USFDA) in March 2020, has received the Establishment Inspection Report (EIR), thereby confirming the successful closure of the inspections. The announcement was made before market hours today, 26 March 2020.

On a consolidated basis, the drug maker's net profit slumped 68% to Rs 93.89 crore despite a 28.5% rise in net sales to Rs 732.44 crore in Q3 December 2019 over Q3 December 2018.

Strides Pharma Science is a global pharmaceutical company. It focuses on difficult to manufacture products that are sold in over 100 countries.

The scrip was down 0.75% at Rs 317.25. It was trading in the range of Rs 312 to Rs 346.20 so far.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 13942648
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd